The Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) was established to address anticipated needs for post-marketed evidence generation for novel biologics, their corresponding biosimilars and other related products.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Susan Cantrell, AMCP CEO, to discuss the significance of the recent passage of the Pre-approval Information Exchange (PIE) Act of 2022.
January 2023 News & Views: AMCP Applauds Congressional Passage of PIE Act; AMCP Welcomes Two New Affiliates; Congratulations to AMCP’s Newly Elected 2023-2024 Board of Directors.
December 2022 News & Views: AMCP 2023 Registration is Now Open; PIE Act Gains Bipartisan Momentum Ahead of End-of-Year Push; Submit Your Comments for Proposed AMCP Bylaws Amendments by Jan. 25; Access the Latest AMCP Learn Programs Today.
November 2022 News & Views: Guest Blog: Exploring Lessons Learned During the AMCP Summit on Addressing Health Disparities; A Simple Way To Safely Accelerate Patient Access To New Therapies; Celebrate the Best in Managed Care Pharmacy; Save the Date: GivingTuesday is Nov. 29.
October 2022 News & Views: FDA Awards $1.3 Million Grant to Biologics & Biosimilars Collective Intelligence Consortium; Act Now to Sign Up for Specialty Connect; Celebrate the Best in Managed Care Pharmacy –AMCP Award Nominations are Now Open.
September 2022 News & Views: Reserve Your Spot for the AMCP Summit on Value and Access; Join Your Colleagues in National Harbor, Md. For Nexus 2022; AMCP Summit on Addressing Health Disparities: Top 10 Takeaways; Join AMCP Foundation’s 5K For the Future During Nexus 2022.
